share_log

Jefferies Upgrades GSK to Buy, Raises Price Target to $48

Benzinga ·  Jan 3 05:46

Jefferies analyst Peter Welford upgrades GSK (NYSE:GSK) from Hold to Buy and raises the price target from $38.5 to $48.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment